Prodigiosin
"Prodigiosin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)- 2,2'-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.
| Descriptor ID |
D011353
|
| MeSH Number(s) |
D03.383.129.578.748 D23.767.778
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prodigiosin".
Below are MeSH descriptors whose meaning is more specific than "Prodigiosin".
This graph shows the total number of publications written about "Prodigiosin" by people in this website by year, and whether "Prodigiosin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prodigiosin" by people in Profiles.
-
Soto-Cerrato V, Vi?als F, Lambert JR, P?rez-Tom?s R. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway. Biochem Pharmacol. 2007 Nov 01; 74(9):1340-9.
-
Soto-Cerrato V, Vi?als F, Lambert JR, Kelly JA, P?rez-Tom?s R. Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3beta activity in human breast cancer cells. Mol Cancer Ther. 2007 Jan; 6(1):362-9.